4-Substituted Benzenesulfonamides Incorporating Bi/Tricyclic Moieties Act as Potent and Isoform-Selective Carbonic Anhydrase II/IX Inhibitors
Silvia Salerno(University of Pisa), Sabrina Taliani(University of Pisa), Claudiu T. Supuran(University of Florence), Giorgio Amendola(University of Campania "Luigi Vanvitelli"), Ettore Novellino(Università Cattolica del Sacro Cuore), Elisabetta Barresi(University of Pisa), Ciro Milite(University of Salerno), Sandro Cosconati, Federico Da Settimo(University of Pisa), Anna María Marini(University of Pisa), Emanuela Berrino(Link Campus University)
Cited by 23
Related Papers
Natural products in drug discovery: advances and opportunities
|Nature Reviews Drug Discovery|2021|5k
Interfering with pH regulation in tumours as a therapeutic strategy
|Nature Reviews Drug Discovery|2011|1.5k
How many carbonic anhydrase inhibition mechanisms exist?
|Journal of Enzyme Inhibition and Medicinal Chemistry|2015|724
Structure-based drug discovery of carbonic anhydrase inhibitors
|Journal of Enzyme Inhibition and Medicinal Chemistry|2012|608
Rosmarinic acid inhibits some metabolic enzymes including glutathione<i>S</i>-transferase, lactoperoxidase, acetylcholinesterase, butyrylcholinesterase and carbonic anhydrase isoenzymes
|Journal of Enzyme Inhibition and Medicinal Chemistry|2016|228